Want to create an interactive transcript for this episode?
Podcast: Clinician's Roundtable
Episode: How Biologic Insights Are Refining Severe Asthma Care
Description:
Presenter: Sally E. Wenzel, MD, ATSF
Given that severe asthma management is entering a new era of biologically driven precision, Dr. Sally Wenzel joins us to discuss the complexity within Type 2 inflammation and the limitations of relying on a single biomarker assessment. She also differentiates childhood-onset allergic asthma from adult-onset disease, underscoring how age of onset—along with underlying biology—can inform therapeutic strategy. Dr. Wenzel serves as the Director of the Asthma Institute at UPMC, and she spoke about this topic at the 2026 American Academy of Allergy, Asthma, and Immunology Annual Meeting.